Walleye Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63K | Sell |
66
-32,705
| -100% | -$1.8M | ﹤0.01% | 1804 |
|
|
2025
Q1 | $2.32M | Buy |
32,771
+4,699
| +17% | +$332K | 0.01% | 558 |
|
|
2024
Q4 | $1.85M | Sell |
28,072
-127,370
| -82% | -$8.37M | ﹤0.01% | 725 |
|
|
2024
Q3 | $10.9M | Buy |
155,442
+117,119
| +306% | +$8.23M | 0.02% | 246 |
|
|
2024
Q2 | $3.16M | Buy |
38,323
+3,639
| +10% | +$300K | 0.01% | 615 |
|
|
2024
Q1 | $3.03M | Buy |
34,684
+22,111
| +176% | +$1.93M | 0.01% | 624 |
|
|
2023
Q4 | $1.21M | Buy |
12,573
+7,572
| +151% | +$730K | ﹤0.01% | 829 |
|
|
2023
Q3 | $442K | Sell |
5,001
-43,638
| -90% | -$3.86M | ﹤0.01% | 1185 |
|
|
2023
Q2 | $4.22M | Sell |
48,639
-88,633
| -65% | -$7.68M | 0.02% | 334 |
|
|
2023
Q1 | $13.3M | Buy |
137,272
+71,798
| +110% | +$6.98M | 0.2% | 92 |
|
|
2022
Q4 | $6.78M | Sell |
65,474
-27,272
| -29% | -$2.82M | 0.12% | 198 |
|
|
2022
Q3 | $7.86M | Buy |
92,746
+52,496
| +130% | +$4.45M | 0.15% | 139 |
|
|
2022
Q2 | $3.34M | Sell |
40,250
-75,399
| -65% | -$6.25M | 0.09% | 238 |
|
|
2022
Q1 | $8.92M | Buy |
115,649
+104,154
| +906% | +$8.03M | 0.24% | 82 |
|
|
2021
Q4 | $1.02M | Buy |
+11,495
| New | +$1.02M | 0.03% | 568 |
|
|
2021
Q3 | – | Sell |
-3,560
| Closed | -$297 | – | 1573 |
|
|
2021
Q2 | $297 | Buy |
+3,560
| New | +$297 | 0.01% | 923 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 559 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 690 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 545 |
|
|
2019
Q2 | – | Sell |
-822
| Closed | -$73K | – | 533 |
|
|
2019
Q1 | $73K | Buy |
+822
| New | +$73K | 0.01% | 184 |
|